Company:  ROCK CREEK PHARMACEUTICAL ... (RCPIQ)
Form Type:  8-K
Filing Date:  3/4/2011 
CIK:  0000776008 
Address:  2040 WHITFIELD AVENUE
SUITE 300
 
City, State, Zip:  SARASOTA, Florida 34243 
Telephone:  804-527-1970 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.00  
Change: 
0.00 (0.00%)  
Trade Time: 
Jul 19  
Market Cap: 
$0.00M
Trade RCPIQ now with 

© 2019  
Description of Business
We are a pharmaceutical development company focused on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders, utilizing our proprietary compounds. Our development activities are currently focused on our lead compound, anatabine citrate, which, based on our accumulated data, we believe demonstrates anti-inflammatory properties. Prior to September 2014, we marketed and sold an anatabine-based dietary supplement under the name Anatabloc ®, together with other anatabine-based products. We discontinued the marketing and sale of such products in September 2014 and have changed the focus of our Company to pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. Our strategy is to leverage the underlying science and clinical data we have generated and accumulated to advance our pharmaceutical development program.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02 Unregistered Sale of Equity Securities.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 10.2